End-Expiratory Lung Volume in Children Awakening From Propofol Anesthesia
NCT ID: NCT05821114
Last Updated: 2023-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
52 participants
INTERVENTIONAL
2023-04-07
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* High flow oxygen can decrease the occurence of atelectasis during awakening from propofol anesthesia in pediatric patients?
* Head elevation can decrease the occurence of atelectasis during awakening from propofol anesthesia in pediatric patients?
Researchers will compare high flow oxygen vs low flow oxygen group to see if the use of high flow oxygen decrease the occurence of atelectasis during awakening from propofol anesthesia.
And in each group, the patients will be assigned to supine position vs head elevation position to compare the effects of head elevation during awakening from propofol anesthesia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-flow Nasal Oxygenation During Preoxygenation and Atelectasis
NCT06205212
Postoperative Atelectasis in Pediatric Patients With Prone Position
NCT03486847
Observation of Atelectasis Using Lung Ultrasonography in Children Undergoing General Anesthesia: the Cohort Study for Evaluation of the Relationship Between the Incidence and Severity of Upper Respiratory Tract Infection and the Magnitude of Anesthesia-induced Atelectasis
NCT03355547
Determination of Optimal Positive End-expiratory Pressure Using Electrical Impedance Tomography in Children Under General Anesthesia: Comparison Between Supine and Prone Positions
NCT05275309
Lung Atelectasis Improvement Through Positive End Expiratory Pressure During Anesthetic Induction
NCT06900426
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high flow oxygen
Oxygen supply (2L/kg/min.) during awakening from propofol anesthesia
Head elevation_H
High flow\_Head-elevation
Supine_H
High flow\_Supine
Low flow oxygen
Oxygen supply (0.3L/kg/min.) during awakening from propofol anesthesia
Head elevation_L
Low flow\_head elevation
Supine_L
Low flow\_supine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Head elevation_H
High flow\_Head-elevation
Supine_H
High flow\_Supine
Head elevation_L
Low flow\_head elevation
Supine_L
Low flow\_supine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* less than 1 months
* cyanotic patients
1 Month
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hee-Soo Kim
professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hee-Soo Kim
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2302-129-1408
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.